Abstract
In December 2024, the European Association for the Study of the Liver (EASL) released the 2024 edition of EASL clinical practice guidelines: management of hepatocellular carci-noma (HCC). Compared to the 2018 edition, the 2024 edition includes significant updates in several areas, such as personalized surveillance strategies based on individual risk assessment, standardiza-tion of liver imaging protocols and diagnostic criteria, the use of minimally invasive surgical approaches in complex cases, an updated approach to liver transplantation integration, transitions between surgery, locoregional, and systemic therapies, as well as the positioning of radiotherapy and the use of combination immunotherapy at various stages of the disease. The authors systematically interpret the main updates related to treatment strategies in the new guidelines, aiming to provide clinicians with clear decision-making references for treatment.
| Translated title of the contribution | Progress in the update of 2024 European Association for the Study of the Liver clinical practice guidelines for management of hepatocellular carcinoma |
|---|---|
| Original language | Chinese (Traditional) |
| Pages (from-to) | 198-205 |
| Number of pages | 8 |
| Journal | Chinese Journal of Digestive Surgery |
| Volume | 24 |
| Issue number | 2 |
| DOIs | |
| State | Published - 20 Feb 2025 |
| Externally published | Yes |
Keywords
- Clinical prac-tice guidelines
- Interpretation
- Liver neoplasms
- Multidisciplinary team
- Treatment strategies